ACAD
32.46
-1.9
-5.53%
AEMD
5.31
-0.25
-4.50%
APRI
0.351
-0.011
-3.0370%
ARNA
1.59
-0.09
-5.36%
ATEC
0.3
-0.01
-3.23%
CNAT
1.93
0.00
0.00%
CRXM
0.171
0.00
0.00%
CYTX
2.07
-0.12
-5.48%
DXCM
90.35
-1.74
-1.89%
GNMK
8.75
-0.05
-0.57%
HALO
9.42
-0.68
-6.73%
ILMN
169.54
-3.25
-1.88%
INNV
0.42
-0.03
-7.75%
INO
8.57
-0.57
-6.24%
ISCO
2
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
102.4
-5.67
-5.25%
LPTN
2.83
+0.15
+5.60%
MBVX
5.1
-0.25
-4.6748%
MEIP
1.97
-0.08
-3.90%
MNOV
6.4
-0.15
-2.29%
MRTX
5.32
-0.14
-2.56%
MSTX
0.402
-0.013
-3.0602%
NBIX
49.44
-2.06
-4.00%
NUVA
63.16
-0.94
-1.47%
ONCS
1.73
-0.07
-3.72%
ONVO
3.8
-0.21
-5.24%
OREX
4.02
-0.32
-7.37%
OTIC
16.21
-1.05
-6.08%
QDEL
21.53
-0.02
-0.09%
RCPT
231.96
0.00
0.00%
RGLS
3.22
-0.22
-6.40%
RMD
68
+0.68
+1.01%
SCIE
0.004
+0.00
+4.4776%
SPHS
3.38
-0.51
-13.11%
SRNE
6.43
-0.53
-7.61%
TROV
5.06
-0.15
-2.88%
VICL
3.97
-0.13
-3.17%
VOLC
18
0.00
0.00%
ZGNX
8.88
-0.68
-7.11%
ACAD
32.46
-1.9
-5.53%
AEMD
5.31
-0.25
-4.50%
APRI
0.351
-0.011
-3.0370%
ARNA
1.59
-0.09
-5.36%
ATEC
0.3
-0.01
-3.23%
CNAT
1.93
0.00
0.00%
CRXM
0.171
0.00
0.00%
CYTX
2.07
-0.12
-5.48%
DXCM
90.35
-1.74
-1.89%
GNMK
8.75
-0.05
-0.57%
HALO
9.42
-0.68
-6.73%
ILMN
169.54
-3.25
-1.88%
INNV
0.42
-0.03
-7.75%
INO
8.57
-0.57
-6.24%
ISCO
2
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
102.4
-5.67
-5.25%
LPTN
2.83
+0.15
+5.60%
MBVX
5.1
-0.25
-4.6748%
MEIP
1.97
-0.08
-3.90%
MNOV
6.4
-0.15
-2.29%
MRTX
5.32
-0.14
-2.56%
MSTX
0.402
-0.013
-3.0602%
NBIX
49.44
-2.06
-4.00%
NUVA
63.16
-0.94
-1.47%
ONCS
1.73
-0.07
-3.72%
ONVO
3.8
-0.21
-5.24%
OREX
4.02
-0.32
-7.37%
OTIC
16.21
-1.05
-6.08%
QDEL
21.53
-0.02
-0.09%
RCPT
231.96
0.00
0.00%
RGLS
3.22
-0.22
-6.40%
RMD
68
+0.68
+1.01%
SCIE
0.004
+0.00
+4.4776%
SPHS
3.38
-0.51
-13.11%
SRNE
6.43
-0.53
-7.61%
TROV
5.06
-0.15
-2.88%
VICL
3.97
-0.13
-3.17%
VOLC
18
0.00
0.00%
ZGNX
8.88
-0.68
-7.11%
Home » Archive by Category

Diagnostics

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

August 26, 2011 – 9:57 am

The Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through …

SDBN August 16th 2011 Event Featuring Pathway Genomics

July 29, 2011 – 9:41 am

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for …